AAAAAA
Results:
1-7
|
Results: 7
Authors:
Busse, D
Yakes, FM
Lenferink, AEG
Arteaga, CL
Citation: D. Busse et al., Tyrosine kinase inhibitors: Rationale, mechanisms of action, and implications for drug resistance, SEMIN ONCOL, 28(5), 2001, pp. 47-55
Authors:
Muraoka, RS
Lenferink, AEG
Simpson, J
Brantley, DM
Roebuck, LR
Yakes, FM
Arteaga, CL
Citation: Rs. Muraoka et al., Cyclin-dependent kinase inhibitor p27(Kip1) is required for mouse mammary gland morphogenesis and function, J CELL BIOL, 153(5), 2001, pp. 917-931
Authors:
Lenferink, AEG
Busse, D
Flanagan, WM
Yakes, FM
Arteaga, CL
Citation: Aeg. Lenferink et al., ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways, CANCER RES, 61(17), 2001, pp. 6583-6591
Authors:
Lenferink, AEG
Simpson, JF
Shawver, LK
Coffey, RJ
Forbes, JT
Arteaga, CL
Citation: Aeg. Lenferink et al., Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu plus MMTV/TGF-alpha bigenic mice, P NAS US, 97(17), 2000, pp. 9609-9614
Authors:
Lenferink, AEG
van Zoelen, EJJ
van Vugt, MJH
Grothe, S
van Rotterdam, W
van de Poll, MLM
O'Connor-McCourt, MD
Citation: Aeg. Lenferink et al., Superagonistic activation of ErbB-1 by EGF-related growth factors with enhanced association and dissociation rate constants, J BIOL CHEM, 275(35), 2000, pp. 26748-26753
Authors:
Kurokawa, H
Lenferink, AEG
Simpson, JF
Pisacane, PI
Sliwkowski, MX
Forbes, JT
Arteaga, CL
Citation: H. Kurokawa et al., Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-ovorexpresessed tamoxifen-resistant breast cancer cells, CANCER RES, 60(20), 2000, pp. 5887-5894
Authors:
Lenferink, AEG
de Roos, ADG
van Vugt, MJH
van de Poll, MLM
van Zoelen, EJJ
Citation: Aeg. Lenferink et al., The linear C-terminal regions of epidermal growth factor (EGF) and transforming growth factor-alpha bind to different epitopes on the human EGF receptor, BIOCHEM J, 336, 1998, pp. 147-151
Risultati:
1-7
|